SCHEMBL14224314

SCHEMBL14224314

Bc1cc(C=O)cc(OCC)c1OCCCCCCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.44
L3MBTL1 Q9Y468 4/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
POLB P06746 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 3/20 0.42
HPGD P15428 3/20 0.39
MAPT P10636 3/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TOP2A P11388 1/20 0.37
TACR2 P21452 1/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
S1PR2 O95136 1/20 0.36
S1PR1 P21453 1/20 0.36
S1PR3 Q99500 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1200595 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL6847530 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201087 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201157 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201058 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201339 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201447 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL4937483 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201490 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB
SCHEMBL1201617 0.85 FDPS (0.44) ALDH1A1L3MBTL1KMT2AMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351725-B2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists MERCK & CO., INC. (US) 2008-04-01 US disclosed